Roivant decants another Vant armed with Eisai blood cancer drug and plans to start phase 1/2 soonthetimepressFebruary 14, 2022 by thetimepressFebruary 14, 2022028 Roivant Sciences has spawned another Vant. The latest addition to the clan is Hemavant, a biotech that starts life with a former Eisai drug and... Read more
